vesnarinone has been researched along with bucladesine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ito, M; Itoh, H; Konishi, T; Kusagawa, M; Nakano, T; Shimomura, A; Suga, T | 1 |
Ikeda, U; Kurosaki, K; Maeda, Y; Shimada, K; Shimpo, M; Ueno, S | 1 |
3 other study(ies) available for vesnarinone and bucladesine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Ca2+(-)dependent and Ca2+(-)independent vasorelaxation induced by cardiotonic phosphodiesterase inhibitors.
Topics: Animals; Bucladesine; Calcium; Cardiotonic Agents; Colforsin; In Vitro Techniques; Male; Phosphodiesterase Inhibitors; Pyrazines; Quinolines; Rats; Rats, Wistar; Vasodilation; Verapamil | 1993 |
Effects of vesnarinone on nitric oxide synthesis in rat cardiac myocytes.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Analysis of Variance; Animals; Animals, Newborn; Bucladesine; Cardiotonic Agents; Cells, Cultured; Culture Media, Conditioned; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Dactinomycin; Dose-Response Relationship, Drug; Interleukin-1; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Protein Synthesis Inhibitors; Pyrazines; Quinolines; Rats; Rats, Sprague-Dawley; Thionucleotides; Tumor Necrosis Factor-alpha | 1998 |